Collaboration Tackles Sleep Problems in Parkinson’s

Collaboration Tackles Sleep Problems in Parkinson’s
4.3
(10)

Cambridge Sleep Sciences and Parkinson’s Concierge have entered an agreement to tackle sleep problems in Parkinson’s disease.

Sleep problems such as difficulty falling asleep, daytime sleepiness, and troubled dreams are among the most common non-motor symptoms of Parkinson’s disease. Sleep also can be indirectly affected by other aspects of Parkinson’s, such as anxiety, frequent urination, physical discomfort, and treatment side effects.

There aren’t any universally agreed-upon guidelines for how to treat sleep disturbances in Parkinson’s patients. Such treatment is particularly complicated because some sleep medications may interfere with treatments for Parkinson’s itself. As such, there is a need for non-pharmacological interventions for sleep in Parkinson’s.

Cambridge Sleep Sciences has devoted 10 years of scientific research to develop a new device, called SleepHub, that addresses the causes of poor-quality sleep and insomnia.

“[We] have high hopes for SleepHub improving the lives of many people living with Parkinson’s. At Parkinson’s Concierge we always seek out and promote products and services, gadgets, tech and AI [artificial intelligence] solutions which benefit others living with this condition,” Charlotte Allen and Russ Bradford, co-founders of Parkinson’s Concierge, stated in a press release.

SleepHub has four sleeping modes scientifically designed to act as a natural sleep aid. By using rhythms and pulses in high-quality audio speakers to emulate brain waves produced during sleep, the device restores natural sleep cycles.

A variety of soundscapes complement each mode, enabling the brain to relax and find its natural sleep pattern. Essentially, these sounds act as a guide-track for the brain, retraining it to revert to its natural sleep cycles.

“When Parkinson’s Concierge advised us of anecdotal reports that SleepHub had improved sleep in some of their members, we wanted to explore this further,” said Chris Dickson, executive chairman of Cambridge Sleep Sciences.

Now, the company will be working with Parkinson’s Concierge to assess SleepHub’s effectiveness in patients with Parkinson’s disease before moving forward to clinical trials.

“We are extremely optimistic, having tested SleepHub for about a month now, that this could in turn have an effect on improving the other symptoms people live with as well for our Global Parkinson’s Community,” added Allen and Bradford.

Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.
Total Posts: 208
Ana holds a PhD in Immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. She graduated with a BSc in Genetics from the University of Newcastle and received a Masters in Biomolecular Archaeology from the University of Manchester, England. After leaving the lab to pursue a career in Science Communication, she served as the Director of Science Communication at iMM.
×
Diana holds a PhD in Biomedical Sciences, with specialization in genetics, from Universidade Nova de Lisboa, Portugal. Her work has been focused on enzyme function, human genetics and drug metabolism.
Latest Posts
  • skin cancer link
  • Health Canada
  • NYX-458 trial
  • magnetic nanoparticles, brain function

How useful was this post?

Click on a star to rate it!

Average rating 4.3 / 5. Vote count: 10

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?